Pfizer and Novartis partner up to develop combo therapies for NASH
October 29, 2018Research and Development, Sales and Marketing Novartis, Pfizer, liver, nash, pharma
Pfizer and Novartis are set to team up in a non-exclusive partnership aimed at the clinical development of one or …
HHS Secretary Alex Azar responds to pharma sector’s criticism over Medicare pricing plan
October 29, 2018Sales and Marketing
US Health and Human Services (HHS) Secretary Alex Azar responded to industry criticism on Friday after big pharma warned that …
President Trump unveils new plans to bring US drug prices in line with the rest of the world
October 26, 2018Medical Communications, Sales and Marketing Drug pricing, Trump, US, pharma
Two weeks before the all-important midterm elections in the US, and after repeated strongly-worded promises, President Trump has unveiled an …
Top Ten most popular articles on Pharmafile.com this week!
October 26, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing FDA, GSK, HDA, J&J, JJ, brexit, clinical trials, pharmafile, resutls, stockpiling, top 10
Winter is coming! And with it an assortment of promising and not so promising results from big pharma. While J&J …
India declares Sterling Biotech owners ‘Economic Fugitives’
October 26, 2018Medical Communications India, Modi, Sandesara, Sterling Biotech, corruption
India’s Enforcement Directorate (ED), the country’s law enforcement agency responsible for tackling financial and economic crimes, is using new powers …
NICE issues draft guidance rejecting Abbvie’s Venclyxto in chronic lymphocytic leukaemia
October 26, 2018Medical Communications, Sales and Marketing AbbVie, NHS, NICE, leukaemia, pharma, venetoclax
It’s bad news for patients in the UK affected by chronic lymphocytic leukaemia (CLL) as the National Institute of Health …
Magic mushroom ingredient psilocybin gains breakthrough therapy designation
October 26, 2018Medical Communications Breakthrough Therapy Designation, Compass, FDA, Magic mushrooms, psylicobin
The US Food and Drug Administration (FDA) has given psilocybin – the psychoactive ingredient in ‘magic mushrooms’ – breakthrough therapy …
GSK opens £54m API plant in Montrose, Scotland
October 25, 2018Manufacturing and Production API, GSK, Scotland, manufacturing, montrose
British multinational GlaxoSmithKline has opened an API manufacturing plant in Montrose Scotland for its Ellipta respiratory medicines. The new facility …
Amgen slashes price of cholesterol drug Repatha by 60%
October 25, 2018Sales and Marketing Repatha, cholestrol, drug, medicine, pricing
American multinational Amgen has slashed the price of cholesterol drug Repatha, reducing the medication’s US list price by 60%. The …
FDA generics approvals up 90% compared to 2014
October 25, 2018Sales and Marketing FDA, Trump, generics, pharma
Continuing to build on its successes in toppling previous benchmarks, it has emerged that the FDA’s total number of generic …
Measles outbreak threatens to decimate isolated Amazonian tribe in Venezuela and Brazil
October 25, 2018Medical Communications Brazil, Venezuela, measles, tribe, vaccines, yanomami
An outbreak of measles threatens to decimate an isolated tribe in the Amazon, according to the non-profit organisation Survival International. …
First novel, single-dose flu drug approved in US in almost 20 years
October 25, 2018Sales and Marketing FDA, Shionogi, Xofluza, flu, influenza, pharma
The FDA has announced that it has approved the first single-dose flu drug with a novel mechanism of action in …
UCB and Biogen’s lupus drug falls short at Phase 2b
October 24, 2018Research and Development Biogen, Lupus, UCB, dapirolizumab pegol, pharma, systemic lupus erythematosus, trial falure
The partnership of UCB and Biogen announced disappointing news, confirming that its experimental therapy dapirolizumab pegol (DZP) failed to meet …
New $2 million programme aims at increasing diversity in cancer research
October 24, 2018Research and Development Cancer, USA, black, cancer research, diversity, latino, native american
The National Cancer Institute are developing a joint cancer drug discovery and development, and research education programme focused towards the …
Pfizer & Lilly’s non-opioid drug reduces pain in osteoarthritis
October 24, 2018Research and Development Eli Lilly, Pfizer, osteoarthritis, pharma
Pfizer and Eli Lilly have announced data revealing that their nerve growth factor (NGF) inhibitor tanezumab met all three of …
Industry leaders warn public may have to stockpile medicines in case of no-deal Brexit
October 24, 2018Research and Development brexit, no-deal Brexit, stockpiling
Martin Sawer, the executive director of the Healthcare Distribution Association (HDA) – formerly the British Association of Pharmaceutical Wholesalers (BAPW) …
Guangdong bans transportation of pigs due to African swine fever outbreak in Hunan
October 23, 2018Research and Development ASF, African swine fever, China, Guangdong, Hunan, animal health
Chinese authorities have banned the transportation of live pigs from Guangdong to other regions, after reports of African swine fever …
Roche’s Alecensa topples Pfizer’s Xalkori in Asian patients with ALK+ advanced lung cancer
October 23, 2018Manufacturing and Production, Research and Development Alecensa, Cancer, ESMO 2018, Roche, lung cancer, pharma
Following up on the reveal of data concerning its immunotherapy Tecentriq in combination with chemotherapy in the treatment of non-small …
First-line Keytruda shows better overall survival in head & neck cancer
October 23, 2018Manufacturing and Production, Research and Development Cancer, ESMO 2018, MSD, head and neck cancer, keytruda, pharma
MSD’s Keytruda (pembrolizumab) made an impact at the European Society for Medical Oncology 2018 Congress as the company unveiled new …
Shares in Mirati plummet after disappointing Phase II trial
October 23, 2018Manufacturing and Production Cancer, Mirati, leuakemia, plummet, stocks
Shares in the California-based biotech Mirati Therapuetics plummeted on Monday after the company released disappointing results from their Phase II …
Latest content
Five Facts about NHS and primary care
AI in pharma: From lab development to patient impact
